NVIDIA video chip on the motherboard] Antonio Bordunovi What are the best hardware stocks right now? We asked Seeking Alpha analysts Livy Investment Research [ and Kenio Fontes [ for their picks. Livy ...

The new week kicks off with Apple’s Worldwide Developers Conference that runs from Monday through Friday. The Apple faithful are hoping for good news that can jump-start the shares of the iPhone maker ...

Asking for a Trend's Josh Lipton takes a look ahead to this week's biggest earnings releases, including video game retailer GameStop (GME), creative software developer Adobe (ADBE), and Oracle (ORCL).

Bank of America analysts say President Trump’s recent remarks about Fannie Mae and Freddie Mac signal a shift in housing policy direction under a potential seco ...

Broadcom’s stock is the fifth-best-performing in the S&P 500 over the past two months, rising more than 70% over the period—a stunning rise given the company’s already large size. Years ago, Broadcom ...

International Business Machines (IBM, Financials) was among the bidders for Informatica (INFA, Financials) prior to the $8 billion acquisition by Salesforce (CRM, Financials), people familiar with the ...

Of the 22 guru strategies we follow, HES rates highest using our Acquirer's Multiple Investor model based on the published strategy of Tobias Carlisle. This deep value model looks for inexpensive ...

Scotiabank analyst Ovais Habib raised the firm’s price target on Orla Mining (ORLA) to C$16 from C$15.50 and keeps an Outperform rating on the shares. Scotia noted that Orla reported its first ...

BofA analyst Brad Sills lowered the firm’s price target on DocuSign (DOCU) to $85 from $88 and keeps a Neutral rating on the shares, calling Q1 results “somewhat disappointing.” The magnitude of the ...

Criminals exploit the trust teens have in iPhone messaging, and use the platform to make relentless demands for money. Continue Reading View comments ...

Google are increasing as the U.S. Department of Justice’s search antitrust case nears a decision, with remedies ...

BioCryst Pharmaceuticals (BCRX) announced that ORLADEYO (berotralstat) has been approved for national reimbursement in the Netherlands for routine prevention of hereditary angioedema (HAE) attacks in ...